Drug-induced lung disease adverse effect with Ledipasvir Acetonate/Sofosbuvir.

Omotani, Sachiko; Ishizaka, Toshihiko; Inoue, Miki; Nishida, Koji; Yasui, Yukako; Hatsuda, Yasutoshi; Mukai, Junji; Myotoku, Michiaki

Omotani, Sachiko; Ishizaka, Toshihiko; Inoue, Miki; Nishida, Koji; Yasui, Yukako; Hatsuda, Yasutoshi; Mukai, Junji; Myotoku, Michiaki.

Afiliación

Omotani S; 1Laboratory of Practical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1, Nishikiori-kita, Tondabayashi, Osaka, 584-8540 Japan.
Ishizaka T; Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai, Osaka, 593-8304 Japan.
Inoue M; Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai, Osaka, 593-8304 Japan.
Nishida K; Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai, Osaka, 593-8304 Japan.
Yasui Y; Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai, Osaka, 593-8304 Japan.
Hatsuda Y; Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai, Osaka, 593-8304 Japan.
Mukai J; 1Laboratory of Practical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1, Nishikiori-kita, Tondabayashi, Osaka, 584-8540 Japan.
Myotoku M; 1Laboratory of Practical Pharmacy and Pharmaceutical Care, Faculty of Pharmacy, Osaka Ohtani University, 3-11-1, Nishikiori-kita, Tondabayashi, Osaka, 584-8540 Japan.

J Pharm Health Care Sci ; 6: 6, 2020.

Article en En | MEDLINE | ID: mdl-32266075

Palabras clave

Chronic hepatitis C; Direct acting antivirals (DAAs); Drug-induced lung disease; Interstitial lung disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pharm Health Care Sci Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pharm Health Care Sci Año: 2020 Tipo del documento: Article